Description
Useful in the evaluation and diagnosis of bleeding disorders, leukaemia states, disseminated intravascular coagulation, purpura and drug induced thrombocytopenia.
Indications
Platelet count is reduced in malignancies, cytotoxic chemotherapy, autoimmune thrombocytopenic purpura, splenomegaly and multiply transfused patients, hereditary diseases such as Wiscott-Aldrich syndrome, Fanconi’s syndrome, Chediak-Higashi anomaly and Bernard-Soulier syndrome. Increased platelets counts are seen in chronic hemorrhage, essential thrombocythemia, polycythemia vera, vasculitides, inflammatory disorders and post-splenectomy.
Sample Type, Quantity & Conditions
1 ml EDTA Whole Blood Room Temperature
Special Precautions
Normal Range
≥ 15 years: 150000-400000 /μL 150 - 400 x10^9/L < 15 years: 150000-450000/μL 150-450x10^9/L
